Furthermore, analysis of the tumor-infiltrating lymphocytes on day 14 revealed that Fcgr2b–/– CD8+ CD45.2+ OT-I T cells were present at significantly increased frequencies within the tumor relative to WT OT-I control cells (Figure 4, F and G). The gene discussed is CD8A; the disease is neoplasm.